Rebooting the Eye To test this theory, the team injected an anesthetic called tetrodotoxin into the lazy eye of lab animals ...
Vision loss has long been treated as a one-way street, a devastating endpoint rather than a problem the brain might quietly ...
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients.